| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Property, plant and equipment, net | 3,581 | |||
| Prepaid expenses and other current assets | 3,484 | |||
| Inventory, net | 830 | |||
| Cash and cash equivalents | 169 | |||
| Marketable securities, available for sale | 2 | |||
| Current assets in discontinued operations | 0 | |||
| Accounts receivable, net | 20,086 | |||
| Total current assets | 24,571 | |||
| Prepaid expenses, net of current portion | 151 | |||
| Other assets | 3 | |||
| Operating lease right-of-use asset, net | 45 | |||
| Intangible assets, net | 8,459 | |||
| Goodwill | 5,231 | |||
| Non-current assets in discontinued operations | 0 | |||
| Total assets | 42,041 | |||
| Unsecured debt-JXVIINote | 0 | |||
| Unsecured debt-ERCClaim | 436 | |||
| Operating lease liabilities, net of current portion | 0 | |||
| Non-current liabilities in discontinued operations | 0 | |||
| Finance lease liabilities, net of current portion | 1,889 | |||
| Deferred revenue, net of current portion | 654 | |||
| Due to sellers (see note 3) | 2,000 | |||
| Total non-current liabilities | 4,979 | |||
| Income tax payable | 1,374 | |||
| Short-term loan payable-Related Party | 389 | |||
| Short-term loan payable-Nonrelated Party | 2,425 | |||
| Other current liabilities | 1,765 | |||
| Operating lease liabilities | 102 | |||
| Current liabilities in discontinued operations | 0 | |||
| Finance lease liabilities | 2,625 | |||
| Deferred revenue | 1,418 | |||
| Accrued diagnostic services | 75 | |||
| Accrued advertising and other allowances | 151 | |||
| Accounts payable | 15,032 | |||
| Warrant liability | 270 | |||
| Total current liabilities | 25,626 | |||
| Total liabilities | 30,605 | |||
| Treasury stock, at cost, 8,692,005 and 12,940,967 shares , respectively | 49,643 | |||
| Accumulated deficit | -58,899 | |||
| Common stock authorized 50,000,000, 0.0005 par value, 41,541,205 and 29,874,029 shares outstanding, respectively | 29 | |||
| Additional paid-in capital | 120,145 | |||
| Accumulated other comprehensive loss | -196 | |||
| Total stockholders equity | 11,436 | |||
| Total liabilities and stockholders equity | 42,041 | |||
ProPhase Labs, Inc. (PRPH)
ProPhase Labs, Inc. (PRPH)